Raymond James Financial Inc. Makes New $16.62 Million Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
Raymond James Financial Inc. bought a new position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 53,846 shares of the biopharmaceutical company’s stock, valued at approximately $16,615,000. Several other hedge funds also recently bought and sold […]
Raymond James Financial Inc. bought a new position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 53,846 shares of the biopharmaceutical company’s stock, valued at approximately $16,615,000. Several other hedge funds also recently bought and sold […]
